Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
1 other identifier
interventional
36
1 country
1
Brief Summary
The study aims to test the non-inferiority of an Allogenic Dermal Matrix with Platelet-Rich Fibrin for treatment of gingival recessions in comparison to the Connective Tissue Graft.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedStudy Start
First participant enrolled
April 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2024
CompletedJuly 12, 2024
July 1, 2024
11 months
March 21, 2023
July 10, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Mean root coverage (mRC)
Measured as a percentage of the total baseline recession defect that coverage was obtained at.
Assessed at 6 months
Complete root coverage (CRC)
Measured as a percentage of total treated sites, that obtained a full coverage of the recession defect
Assessed at 6 months
Keratinized tissue (KT) gain
Measured in mm
Assessed at 6 months
Gingival thickness (GT) gain
Measured in mm
Assessed at 6 months
Patient-reported outcomes (PROMs)
In terms of pain/discomfort at the palatal donor site or patient's arm. Measured using a scale from 0 (lowest) to 10 (highest).
Measured from the day of the procedure up to a maximum of 1 month
Duration of surgical procedure
Including the length of surgical procedure, drawing of blood, and preparation of PRF, harvesting of the autogenous CTG. Measured in minutes.
During surgery
Secondary Outcomes (7)
Professionally evaluated esthetic score
Assessed at 6 months
Soft tissue volume changes over time
Changes of from baseline (prior to treatment) compared with 3 and 6 months
Soft tissue volume changes over time
Measured throughout the study to assess changes from immediate post-op (right after the completion of surgical appointment) until the final recall at 6 months
Soft tissue blood flow changes over time
Measured throughout the study to assess changes from immediate post-op (right after the completion of surgical appointment) until the final recall at 6 months
Patient-reported esthetics
Measured at baseline and at 6 months, and compared between these time points to provide subjective esthetic results
- +2 more secondary outcomes
Study Arms (2)
Connective Tissue Graft
ACTIVE COMPARATORA connective tissue graft from the patient's palate will be used
Allogenic Dermal Matrix with Platelet-Rich Fibrin
EXPERIMENTALAn allogenic dermal matrix with the patient's platelet-rich fibrin will be used
Interventions
Describes the flap design for both treatment arms
Eligibility Criteria
You may qualify if:
- Periodontally and systemically healthy adults
- Full-mouth plaque score and full-mouth bleeding score ≤ 20%
- Presence of at least one 3 mm or deeper gingival recession, with at least 1.5 mm of Keratinized tissue, and 1 mm of gingival thickness) requiring surgical intervention for root coverage
- No interproximal attachment/bone loss
- No prior experience of root coverage procedures within the last 1 year
- The patient must be able to perform good oral hygiene
You may not qualify if:
- Contraindications for undergoing periodontal surgery
- Teeth with more than Grade II mobility, or furcation involvement of Class III
- Patients pregnant or attempting to get pregnant (self-reported), or nursing women
- Untreated/active periodontitis, or other untreated acute infections at the surgical site
- Untreated malignancies at the surgical site
- Persistence of uncorrected gingival trauma from traumatic toothbrushing
- Presence of severe tooth malposition, rotation or clinically significant super-eruption
- Self-reported current smoking more than 10 cigarettes/day or pipe or cigar smoking, or active tobacco chewing, or chronic vaping
- Patients with any known history of blood disorders or complications such as abnormal concentration of thrombin and factor XIII in plasma, or hemophilia
- Patients with significant co-morbidities, such as obesity, uncontrolled diabetes, immunosuppression, severe endocrine-induced bone diseases, signs of malnourishment, those receiving immunosuppressive therapy, poor tissue oxygenation or perfusion, and pre- or post-operative radiation
- Patients with known sensitivity to Polysorbate 20, Cefoxitin, Lincomycin, polymyxin B, Vancomycin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan - Ann Arbor
Ann Arbor, Michigan, 48109, United States
Related Publications (3)
Barootchi S, Tavelli L. Tunneled coronally advanced flap for the treatment of isolated gingival recessions with deficient papilla. Int J Esthet Dent. 2022 Feb 17;17(1):14-26.
PMID: 35175005BACKGROUNDBarootchi S, Giannobile WV, Tavelli L. PDGF-BB-enriched collagen matrix to treat multiple gingival recessions with the tunneled coronally advanced flap. Clin Adv Periodontics. 2022 Dec;12(4):224-232. doi: 10.1002/cap.10211. Epub 2022 Oct 24.
PMID: 35665500BACKGROUNDTavelli L, Barootchi S. A Minimally Invasive Approach for the Treatment of Multiple Adjacent Gingival Recessions with a Volume-Stable Collagen Matrix: A Case Series. Int J Periodontics Restorative Dent. 2022 Mar-Apr;42(2):155-162. doi: 10.11607/prd.5747.
PMID: 35353081BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hom-Lay Wang, DDS MSD PhD
University of Michigan
- PRINCIPAL INVESTIGATOR
Shayan Barootchi, DMD, MS
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 19, 2023
Study Start
April 29, 2023
Primary Completion
March 27, 2024
Study Completion
March 27, 2024
Last Updated
July 12, 2024
Record last verified: 2024-07